48,466
edits
Difference between revisions of "Tyrosine kinase inhibitors"
Jump to navigation
Jump to search
Tyrosine kinase inhibitors (view source)
Revision as of 15:06, 20 October 2014
, 15:06, 20 October 2014no edit summary
| Line 7: | Line 7: | ||
Others - used in [[RCC]]:<ref>URL: [http://dtb.bmj.com/content/49/11/129.abstract http://dtb.bmj.com/content/49/11/129.abstract]. Accessed on: 3 October 2014</ref> | Others - used in [[RCC]]:<ref>URL: [http://dtb.bmj.com/content/49/11/129.abstract http://dtb.bmj.com/content/49/11/129.abstract]. Accessed on: 3 October 2014</ref> | ||
* Sunitinib (Sutent). | * [[Sunitinib]] (Sutent). | ||
* Sorafenib (Nexavar). | * Sorafenib (Nexavar). | ||
* Pazopanib (Votrient). | * Pazopanib (Votrient). | ||